As of March 31, 2017, Mylan Pharmaceuticals has issued a voluntary recall for Epi Pen and Epi Pen Jr, epinephrine autoinjectors, from 13 specified lots.
The recall is due to a potential defective part that would result in the devices’ failure to activate. Although there have been a small number of defective devices reported, Mylan is taking proactive actions to ensure the safety of their products.
The recalled products were distributed between Dec. 17, 2015 and July 1, 2016. Please check your epinephrine autoinjectors and compare with the Mylan Site for lot numbers and steps to return and replace your defective epinephrine autoinjector.
For additional information please view the FDA’s official press release, here.
You may also be interested in . . .
A Deep Dive into Summertime Allergies
As the warmth of summer graces us with its presence, many of us are eager to embrace outdoor activities and soak up the sun. However, along with the…
Stinging Insects & Allergic Reactions
As summer continues marching on, the calendar surely includes upcoming cook-outs, boating on the lake or just a few hours playing in the backyard. The…
5 interesting cases of allergic cross-reactivity
Allergy sufferers cope with their sensitivities in a number of ways, from over-the-counter medication and immunotherapy treatment to simple avoidance.…